TRENTON, N.J. | FDA approves 1st nonopioid drug to ease withdrawal symptoms
TRENTON, N.J. (AP) — Federal regulators have approved the first nonopioid treatment to ease withdrawal symptoms from quitting addictive opioids. The U.S. Food and Drug Administration expedited approval of Lucemyra (luc-eh-MEER’-eh) to help combat the U.S. opioid epidemic. The tablet was approved Wednesday to treat adults for up to two weeks for common withdrawal symptoms … Continue reading TRENTON, N.J. | FDA approves 1st nonopioid drug to ease withdrawal symptoms